Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Casma Therapeutics
38 Sidney Street, Suite 200
Cambridge, MA 02139
https://www.casmatx.com/

Casma Therapeutics is harnessing the natural cellular process of autophagy to open vast new target areas for drug discovery and development. Casma uses several approaches to intervene at strategic points throughout the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens. By boosting autophagy, Casma expects to be able to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders and neurodegeneration, among other indications.

Key Contact
NameTitleE-Mail
Keith Dionne, Ph.D.CEO


Funding Events
DateAmountTypeInvestors
05/03/18$58,500,000Series A Third Rock Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.